Luminopia announced it raised $15.8 Million in an initial filing from an offering of $16.8 Million

Company

Location

About

Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com.